Companion Diagnostics Market Analysis by Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS)), by Indication (Infectious Diseases, Neurological Diseases, Cancer), by End User (Reference Laboratories, Pharmaceutical & Biopharmaceutical Companies), and by Region - Forecast to 2029

Request Sample Page

The global companion diagnostics market size is valued to be USD 3,987.9 million in 2021 and is likely to witness a CAGR of 13.7% during the forecast period. Growing advantages of companion diagnostics is a key driver responsible for the growth of the global companion diagnostics market. Additionally, growth in need for targeted therapy, rise in global incidence of cancer patients, and increasing significance of personalized medicines are some of the other drivers propelling the market growth. However, ambiguous repayment scenario in different regions and lack of knowledge regarding companion diagnostics among developing economies are expected to restrain the global market growth.

Global Ablation Technology Market Size (USD Million), 2021-2029

Source: Erevna Healthcare

By Technology

Based on technology, the market is segmented into in situ hybridization (ISH), polymerase chain reaction (PCR), immunohistochemistry (IHC), Next-generation Sequencing (NGS), and others. In 2021, the Polymerase Chain Reaction (PCR) segment accounted for a significant revenue share and is expected to grow with a lucrative CAGR during the forecast period. This is attributed to the easy application and extensive accessibility of PCR kits & reagents in the companion diagnostic testing worldwide. Next-generation sequencing (NGS) segment is anticipated to grow at a profitable CAGR during the forecast period. This is attributed to major benefits such as high sensitivity for detecting low-frequency variants and lower turnaround time required for high sample volumes.

By Indication

Based on indication, the market is categorized into infectious diseases, neurological diseases, cardiovascular, cancer, and others. In 2021, the cancer segment accounted for a substantial revenue share and is anticipated to grow with a lucrative CAGR during the forecast period. This is due to the increase in incidence of cancer along with a rise in R&D activities for treatment of cancer, worldwide. The infectious diseases segment is anticipated to grow at a profitable CAGR during the forecast period, due to the rising number of FDA permitted companion diagnostics, and increase in attentiveness among the patients regarding the benefits of personalized medicine.

By End User

Based on end user, the market is categorized into reference laboratories, pharmaceutical & biopharmaceutical companies, CROs, and others. In 2021, the pharmaceutical & biopharmaceutical companies segment accounted for a substantial revenue share with lucrative CAGR during the forecast period. This is due to the widespread use of companion diagnostics in these industries because of the growing importance of these companies in drug development worldwide. The reference laboratories segment is anticipated to grow at a profitable CAGR during the forecast period, due to their ability to conduct a wide-ranging number of tests by using companion diagnostics.

Regional Insights

In 2021, North America held the highest revenue share in the global market and is projected to continue its dominance during the forecast period. This is attributed to the increase in the proteomics & genomics research, increase in the share of healthcare expenditure in the per capita income, growth in initiatives from the government, and accessibility of technologically advanced products in the region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period major population base, growing awareness about companion diagnostics among the people, expansion in healthcare infrastructure, and growth in demand for improved therapies.

Competitor Insights

Some of the key players in the companion diagnostics market are F. Hoffmann-La Roche AG (Switzerland); Agilent Technologies, Inc. (U.S.); QIAGEN N.V. (Germany); Abbott Laboratories, Inc. (U.S.); Almac Group (U.K.); Danaher Corporation (U.S.); Illumina, Inc. (U.S.); bioMérieux SA (France); Myriad Genetics, Inc., (U.S.); Sysmex Corporation (Japan); and Thermo Fisher Scientific Inc. (U.S.). The leading players operating in the companion diagnostics industry are adopting various strategies including R&D investments, adaption of advanced techniques, new technology launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The companion diagnostics market report is categorized into the following segments and subsegments:

Companion Diagnostics Market, By Technology (Revenue, USD Million, 2021-2029)

  • In Situ Hybridization (ISH)
  • Polymerase Chain Reaction (PCR)
  • Immunohistochemistry (IHC)
  • Next-Generation Sequencing (NGS)
  • Others

Companion Diagnostics Market, By Indication (Revenue, USD Million, 2021-2029)

  • Infectious Diseases
  • Neurological Diseases
  • Cardiovascular
  • Cancer
    • Breast Cancer
    • Lung Cancer
    • Colorectal Cancer
    • Melanoma
    • Gastric Cancer
  • Others

Companion Diagnostics Market, By End User (Revenue, USD Million, 2021-2029)

  • Reference Laboratories
  • Pharmaceutical & Biopharmaceutical Companies
  • CROs
  • Others

Companion Diagnostics Market, By Region (Revenue, USD Million, 2021-2029)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Scope of Cell Culture Market Report:

Key Parameters Details
Base Year
  • 2021
Forecast Period
  • 2022-2029
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • Value-chain analysis
  • COVID-19 impact analysis
Regional Market Scope
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 15 players
  • 50+ other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Table of Contents: Companion Diagnostics Market 2021-2029

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Assumptions
    4. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Procurement
        1. Internal Database
        2. Secondary Research
        3. Purchased Database
        4. Primary Research
      3. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
      4. Quality Assessment
  1. Introduction: Companion Diagnostics
  2. Executive Summary
    1. Global Market Scenario
    2. Segment Market Scenario
    3. Geographic Market Scenario
    4. COVID-19 Impact
    5. Competitive Landscape
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
      5. Driver 5
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
      4. Restraint 4
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
      4. Opportunity 4
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
      4. Trend 4
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
      4. Challenge 4
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. Value Chain Analysis
    4. SWOT Analysis
    5. Benchmark
  2. COVID-19 Impact Analysis: Companion Diagnostics Market
    1. COVID-19: Overview
    2. COVID-19 Impact on the Global Market
    3. COVID-19 Impact on the Regional Markets
  3. Market Analysis by Technology
    1. In Situ Hybridization (ISH)
      1. In Situ Hybridization (ISH) Market Forecast, 2021-2029 (USD Million)
    2. Polymerase Chain Reaction (PCR)
      1. Polymerase Chain Reaction (PCR) Market Forecast, 2021-2029 (USD Million)
    3. Immunohistochemistry (IHC)
      1. Immunohistochemistry (IHC) Market Forecast, 2021-2029 (USD Million)
    4. Next-Generation Sequencing (NGS)
      1. Next-Generation Sequencing (NGS) Market Forecast, 2021-2029 (USD Million)
    5. Others
      1. Others Market Forecast, 2021-2029 (USD Million)
  1. Market Analysis by Indication
    1. Infectious Diseases
      1. Infectious Diseases Market Forecast, 2021-2029 (USD Million)
    2. Neurological Diseases
      1. Neurological Diseases Market Forecast, 2021-2029 (USD Million)
    3. Cardiovascular
      1. Cardiovascular Market Forecast, 2021-2029 (USD Million)
    4. Cancer
      1. Cancer Market Forecast, 2021-2029 (USD Million)
    5. Others
      1. Others Market Forecast, 2021-2029 (USD Million)
  1. Market Analysis by End User
    1. Reference Laboratories
      1. Reference Laboratories Market Forecast, 2021-2029 (USD Million)
    2. Pharmaceutical & Biopharmaceutical Companies
      1. Pharmaceutical & Biopharmaceutical Companies Market Forecast, 2021-2029 (USD Million)
    3. CROs
      1. CROs Market Forecast, 2021-2029 (USD Million)
    4. Others
      1. Others Market Forecast, 2021-2029 (USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends
    2. Regional Market: Comparative Analysis
  2. North America Companion Diagnostics Market
    1. North America Companion Diagnostics Market
      1. North America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
        2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
        3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
      2. S. Companion Diagnostics Market
        1. S. Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
          2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
          3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
        2. Canada Companion Diagnostics Market
          1. Canada Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
            2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
            3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
  1. Europe Companion Diagnostics Market
    1. Europe Companion Diagnostics Market
      1. Europe Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
        2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
        3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
      2. Germany Companion Diagnostics Market
        1. Germany Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
          2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
          3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
        2. UK Companion Diagnostics Market
          1. UK Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
            2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
            3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
          2. France Companion Diagnostics Market
            1. France Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
              2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
              3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
            2. Spain Companion Diagnostics Market
              1. Spain Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
                2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
                3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
              2. Italy Companion Diagnostics Market
                1. Italy Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
                  3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
                2. Rest of Europe Companion Diagnostics Market
                  1. Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
                    3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
  1. Asia Pacific Companion Diagnostics Market
    1. Asia Pacific Companion Diagnostics Market
      1. Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
        2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
        3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
      2. Japan Companion Diagnostics Market
        1. Japan Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
          2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
          3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
        2. China Companion Diagnostics Market
          1. China Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
            2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
            3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
          2. India Companion Diagnostics Market
            1. India Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
              2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
              3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
            2. South Korea Companion Diagnostics Market
              1. South Korea Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
                2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
                3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
              2. Australia Companion Diagnostics Market
                1. Australia Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
                  3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
                2. Rest of Asia Pacific Companion Diagnostics Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
                    3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
  1. Latin America Companion Diagnostics Market
    1. Latin America Companion Diagnostics Market
      1. Latin America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
        2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
        3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
      2. Brazil Companion Diagnostics Market
        1. Brazil Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
          2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
          3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
        2. Mexico Companion Diagnostics Market
          1. Mexico Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
            2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
            3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
          2. Argentina Companion Diagnostics Market
            1. Argentina Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
              2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
              3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
            2. Rest of Latin America Companion Diagnostics Market
              1. Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
                2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
                3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
  1. MEA Companion Diagnostics Market
    1. MEA Companion Diagnostics Market
      1. MEA Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
        2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
        3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
      2. GCC Companion Diagnostics Market
        1. GCC Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
          2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
          3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
        2. South Africa Companion Diagnostics Market
          1. South Africa Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
            2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
            3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
          2. Rest of MEA Companion Diagnostics Market
            1. Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Technology, 2021-2029 (USD Million)
              2. Market Size and Forecast by Indication, 2021-2029 (USD Million)
              3. Market Size and Forecast byEnd User, 2021-2029 (USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2021 & 2029
    2. Competitive Mapping
    3. Key Players Market Place Analysis
    4. Major Recent Developments
  2. Company Profiles
    1. Hoffmann-La Roche AG (Switzerland)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Indication Benchmarking
      5. Recent Developments
    2. Agilent Technologies, Inc. (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Indication Benchmarking
      5. Recent Developments
    3. QIAGEN N.V. (Germany)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Indication Benchmarking
      5. Recent Developments
    4. Ovizio Imaging Systems (Belgium)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Indication Benchmarking
      5. Recent Developments
    5. Holoxica Ltd. (UK)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Indication Benchmarking
      5. Recent Developments
    6. zSpace, Inc. (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Indication Benchmarking
      5. Recent Developments
    7. Lyncée Tec (Switzerland)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Indication Benchmarking
      5. Recent Developments
    8. Eon Reality (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Indication Benchmarking
      5. Recent Developments
    9. Zebra Imaging (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Indication Benchmarking
      5. Recent Developments
    10. Nanolive SA (Switzerland)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Indication Benchmarking
      5. Recent Developments
    11. Holografika Kft. (Hungary)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    12. Company 12
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    13. Company 13
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    14. Company 14
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    15. Company 15
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    16. Others Prominent Players

Conclusion & Recommendations

Select License Type

Buy Now

7 Reasons to Choose EHMR Reports

  • Customer’s Satisfaction

    First and foremost client’s satisfaction, which is very important for Erevna Healthcare and we are committed towards it

  • Client Report

    Customised reports

    Expert in healthcare domain and in depth insights on the report. Erevna Healthcare also customise reports as per the client’s requirement

  • Analyst Support

    Experienced team of analysts with strong background in Pharma, Life Sciences and Biotechnology

  • Assured Quality

    Each report passes through three tiers of quality check

  • Stick to the timeline

    Stick to the timeline

    Erevna Healthcare analysts stick to the timeline

  • Quick delivery

    Quick delivery of reports as per client’s request in three different forms i.e. pdf, ppt and word

  • 24x7 Supprt

    24*7 Support

    24*7 Support post delivery/dispatch of all the reports

Trending Reports